- Home
- ETJ vs CRMD Comparison
ETJ vs CRMD Comparison
Compare ETJ & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETJ
- CRMD
- Stock Information
- Founded
- ETJ 2007
- CRMD 2006
- Country
- ETJ United States
- CRMD United States
- Employees
- ETJ N/A
- CRMD N/A
- Industry
- ETJ Finance Companies
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- ETJ Finance
- CRMD Health Care
- Exchange
- ETJ Nasdaq
- CRMD Nasdaq
- Market Cap
- ETJ 623.9M
- CRMD 576.4M
- IPO Year
- ETJ N/A
- CRMD 2010
- Fundamental
- Price
- ETJ $9.19
- CRMD $11.11
- Analyst Decision
- ETJ
- CRMD Strong Buy
- Analyst Count
- ETJ 0
- CRMD 5
- Target Price
- ETJ N/A
- CRMD $15.80
- AVG Volume (30 Days)
- ETJ 175.6K
- CRMD 1.2M
- Earning Date
- ETJ 01-01-0001
- CRMD 10-30-2024
- Dividend Yield
- ETJ 8.30%
- CRMD N/A
- EPS Growth
- ETJ N/A
- CRMD N/A
- EPS
- ETJ N/A
- CRMD N/A
- Revenue
- ETJ N/A
- CRMD $12,262,234.00
- Revenue This Year
- ETJ N/A
- CRMD N/A
- Revenue Next Year
- ETJ N/A
- CRMD $277.75
- P/E Ratio
- ETJ N/A
- CRMD N/A
- Revenue Growth
- ETJ N/A
- CRMD 41184.20
- 52 Week Low
- ETJ $7.20
- CRMD $2.89
- 52 Week High
- ETJ $8.47
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- ETJ 43.23
- CRMD 65.46
- Support Level
- ETJ $9.12
- CRMD $7.91
- Resistance Level
- ETJ $9.30
- CRMD $11.00
- Average True Range (ATR)
- ETJ 0.14
- CRMD 0.50
- MACD
- ETJ -0.02
- CRMD 0.34
- Stochastic Oscillator
- ETJ 37.05
- CRMD 90.19
About ETJ Eaton Vance Risk-Managed Diversified Equity Income Fund of Beneficial Interest
Eaton Vance Risk-Managed Diversified Equity Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income and gains, with a secondary objective of capital appreciation. The group invests in various sectors such as financials, healthcare, consumer discretionary, consumer staples, industrials, energy, utilities, telecommunication services, and materials.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.